How is Prostate cancer diagnosed?

['Hör dir diese Seite an']

Wie weurt prostaatkanker gediagnosticeerd?

Prostaatkanker weurt gediagnosticeerd door 'n combinatie vaan tests en procedures, die kinne oonder mie:

1. Digitaal rectaal oonderzeuk (DRE): 'ne Dokter steit 'ne gegluusde, gesmeerde vinger in 't rectum um de prostaat te voele op abnormaliteite.

2. Prostaat-specifiek antigeen (PSA) test: Dit is 'n bloodtest die 't niveau vaan PSA meet, 'n proteïne wat door de prostaat weurt geproduceerd.

Verheve PSA-niveaus kinne de aonwezigheid vaan prostaatkanker aanduide.

3. Transrectaal Ultrasound (TRUS): 'n Klein sonde weurt in 't rectum gezat um 'n beeld vaan de prostaat te make mèt geluidsgolve.

Dit kin helpe bij 't identificere vaan abnormaliteite in de prostaatklier.

4. Biopsie: 'n klein veurbeeld vaan prostaatweefsel weurt oetgenómme en oonder 'n microscoop oonderzeuk nao de aonwezigheid vaan kankercelle.

Dit is de einege definitieve meneer um prostaatkanker te diagnosticere.

5. Magnetic Resonance Imaging (MRI): 'n MRI-scan vaan de prostaat kin helpe bij 't identificere vaan abnormaliteite en de biopsieprocedure begeleie.

6. Genetische teste: Sommege dokters kinne genetische teste gebruke um te bepaole wie agressief de kanker is en behandelbeslute te begeleide.

7. Bone Scan: 'n Bone scan kin weure oetgeveurd um te controlere of de kanker zich heet verspreid nao de beine.

8. Computertomografie (CT) scan: 'n CT-scan kin weure gebruuk um te controlere of de kanker zich heet verspreid nao aander organe of weefsele.

't Is belangriek te merke dat neet alle manslui mèt verhoogde PSA-niveaus of abnormale DRE-resultate prostaatkanker höbbe en neet alle prostaatkanker verhoogde PSA-niveaus zal veroorzake.

Daorum is 'n biopsie nudeg um de diagnose te bevestige.

Daoneve weurt de beslissing um 'n biopsie te oondergaan gemaak nao 't euverweeg vaan de rizzeltaote vaan dees tests en de risicofactoren en veurkeure vaan de individu.

['Verwiezinge']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Saldova R, Fan Y, Fitzpatrick JM, Watson RW, Rudd PM: Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. Glycobiology. 2011, 21 (2): 195-205.

Marenco J, Kasivisvanathan V, Emberton M: New standards in prostate biopsy. Arch Esp Urol. 2019, 72 (2): 142-149.

Moradi M, Mousavi P, Abolmaesumi P: Computer-aided diagnosis of prostate cancer with emphasis on ultrasound-based approaches: a review. Ultrasound Med Biol. 2007, 33 (7): 1010-28.

Cuperlovic-Culf M, Belacel N, Davey M, Ouellette RJ: Multi-gene biomarker panel for reference free prostate cancer diagnosis: determination and independent validation. Biomarkers. 2010, 15 (8): 693-706.

McGrath SE, Michael A, Morgan R, Pandha H: EN2: a novel prostate cancer biomarker. Biomark Med. 2013, 7 (6): 893-901.

An Y, Chang W, Wang W, Wu H, Pu K, Wu A, Qin Z, Tao Y, Yue Z, Wang P, Wang Z: A novel tetrapeptide fluorescence sensor for early diagnosis of prostate cancer based on imaging Zn2+ in healthy versus cancerous cells. J Adv Res. 2020, 24 (): 363-370.

[Consensus of Chinese experts on the application of molecular imaging targeting prostate specific membrane antigen in prostate cancer patients]. Zhonghua Wai Ke Za Zhi. 2018, 56 (2): 91-94.

Zhong WD, He HC, Bi XC, Ou RB, Jiang SA, Liu LS: cDNA macroarray for analysis of gene expression profiles in prostate cancer. Chin Med J (Engl). 2006, 119 (7): 570-3.

['Disclaimer: medisch']

['Dees website is allein veur educatief en informatieve doele en is gein medisch advies of professionele deenste.']

["De verstrekte informatie moot neet weure gebruuk veur 't diagnosticere of behandele vaan 'n gezondheidsprobleem of -krenkde, en lui die medisch advies wèlle höbbe mote 't vraoge aon 'ne gecertificeerde dokter."]

["Bloadn woarin dat de antwoorden op de vraogen in 't neuraal netwark onnauwkeurig bint."]

["Vraog altied advies aon d'n dokter of aon 'n aander gekwalificeerde gezondheidsdeensverlener euver 'n medische toestand. Vergaet noets professioneel medisch advies of vertraog 't in te vraoge umtot get wat geer op dees website höb geleze. Es geer dink tot geer 'n medisch noodgeval höb, bel 911 of geit nao de naoste spoedeisende hulp. Gein arts-patiënt relatie weurt gecreëerd door dees website of 't gebruuk daovaan. Noch BioMedLib noch zien werknemers, noch eedere medewerker aon dees website, maak 'n verklaoring, expliciet of impliciet, mèt betrekking tot de informatie hei of op 't gebruuk daovaan."]

['Disclaimer: copyright']

["De Digital Millennium Copyright Act vaan 1998, 17 U.S.C. § 512 (de DMCA) zörg veur recourse veur copyright-eigenaere die geluive dat materiaal wat op 't internet versjijnt hun rechte oonder de Amerikaanse copyrightwetgeving schendt. "]

["Es geer good geluif dat content of materiaal wat in verband mèt eus website of deenste besjikbaar is, euvertrejt, kinne geer (of eur agent) us 'n berich sture boebij geer vraogt tot de content of 't materiaal weurt verwijderd of tot d'n toegang weurt geblokkeerd."]

['Aankondiginge mote weure gesjtuurd per e-mail (zuug de sectie "Contact" veur e-mailadres).']

["De DMCA vereis dat d'n aovend vaan vermeinde auteursrechsoortreding de volgende informatie bevat: (1) 'n Besjrieving vaan 't auteursrechsbesjermp werk wat 't oonderwerp is vaan de vermeinde euvertreding; (2) 'n Besjrieving vaan de vermeinde euvertrèkkende content en informatie genóg um us de content te laote opspoore; (3) contactinformatie veur diech, inclusief adres, telefoonnummer en e-mailadres; (4) 'n verklaoring vaan diech tot diech good geluif höbs tot de content op de klaagde meneer neet is geautoriseerd door de auteursrechseigenaer, of d'n agent, of door de werking vaan e wèt; "]

["(5) 'n oetlègk vaan diech, oonder straof vaan meineed, dat de informatie in de melding juus is en dat diech de autoriteit höbs um de auteursrechte die weure gesjend te handhaven;"]

["en (6) 'n fysieke of elektronische handtekening vaan de eigenaer vaan 't auteursrech of 'n persoen die gemachtigd is um namens de eigenaer vaan 't auteursrech te handelen. "]

["Es geer neet alle bovestaonde informatie geit geve, kin 't tot gevolg höbbe tot de behandeling vaan eur klach get later weurt."]

['Contact']

['Bitte schick uns eine E-Mail mit irgendwelchen Fragen/Vorschlägen.']

How is prostate cancer diagnosed?

Prostate cancer is diagnosed through a combination of tests and procedures, which may include:

1. Digital Rectal Exam (DRE): A doctor inserts a gloved, lubricated finger into the rectum to feel the prostate for any abnormalities.

2. Prostate-Specific Antigen (PSA) Test: This is a blood test that measures the level of PSA, a protein produced by the prostate gland.

Elevated PSA levels may indicate the presence of prostate cancer.

3. Transrectal Ultrasound (TRUS): A small probe is inserted into the rectum to create an image of the prostate using sound waves.

This can help identify any abnormalities in the prostate gland.

4. Biopsy: A small sample of prostate tissue is removed and examined under a microscope for the presence of cancer cells.

This is the only definitive way to diagnose prostate cancer.

5. Magnetic Resonance Imaging (MRI): An MRI scan of the prostate can help identify any abnormalities and guide the biopsy procedure.

6. Genomic Testing: Some doctors may use genomic tests to help determine the aggressiveness of the cancer and guide treatment decisions.

7. Bone Scan: A bone scan may be performed to check if the cancer has spread to the bones.

8. Computed Tomography (CT) Scan: A CT scan may be used to check if the cancer has spread to other organs or tissues.

It is important to note that not all men with elevated PSA levels or abnormal DRE results will have prostate cancer, and not all prostate cancers will cause elevated PSA levels.

Therefore, a biopsy is necessary to confirm the diagnosis.

Additionally, the decision to undergo a biopsy is made after considering the results of these tests and the individual's risk factors and preferences.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.